Results 31 to 40 of about 313,244 (194)
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors [PDF]
Mesothelin (MSLN) is a cell surface glycoprotein normally expressed only on serosal surfaces, and not found in the parenchyma of vital organs. Many solid tumors also express MSLN, including mesothelioma and pancreatic adenocarcinoma. Due to this favorable expression profile, MSLN represents a viable target for directed anti-neoplastic therapies, such ...
Brendan L. Hagerty +4 more
openaire +3 more sources
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins. [PDF]
The antigen-specific targeting of autoreactive B cells via their unique B cell receptors (BCRs) is a novel and promising alternative to the systemic suppression of humoral immunity.
Diana Klose +8 more
doaj +1 more source
Affinity-Matured Recombinant Immunotoxin Targeting Gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on Malignant Gliomas [PDF]
Darell D. Bigner +2 more
exaly +2 more sources
Both the amplification of the gene coding for wild-type (wt) epidermal growth factor receptor (EGFR) and the overexpression of the EGFR deletion mutant, commonly known as EGFRvIII, are hallmarks of glioblastoma.
Chandramohan, Vidyalakshmi +1 more
core +1 more source
Recombinant immunotoxins for treating cancer
Recombinant immunotoxins are antibody-toxin chimeric molecules that kill cancer cells via binding to a surface antigen, internalization and delivery of the toxin moiety to the cell cytosol. In the cytosol, toxins catalytically inhibit a critical cell function and cause cell death.
David J, FitzGerald +4 more
openaire +2 more sources
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin
Granulysin is a protein present in the granules of human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, with cytolytic activity against microbes and tumors.
Raquel Ibáñez-Pérez +11 more
doaj +1 more source
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
Hepatocellular carcinoma (HCC) accounts for most liver cancers and represents one of the deadliest cancers in the world. Despite the global demand for liver cancer treatments, there remain few options available. The U.S. Food and Drug Administration (FDA)
Bryan D. Fleming, Mitchell Ho
doaj +1 more source
Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical model. [PDF]
Most cancer-specific antigens used as targets of antibody-drug conjugates and immunotoxins are shed from the cell surface (Zhang & Pastan (2008) Clin. Cancer Res. 14: 7981-7986), although at widely varying rates and by different mechanisms (Dello Sbarba &
Youngshang Pak +3 more
doaj +1 more source
Background and purpose: The lack of a new effective treatment for small cell lung cancer (SCLC) is an unresolved problem. Due to the new identification of delta-like ligand 3 (DLL3) and its high expression in SCLC patients, the use of DLL3 in target ...
Mohammad Hossein Ataee +5 more
doaj +1 more source
Bovine herpesvirus 1 (BoHV-1) is a highly contagious viral pathogen which causes infectious bovine rhinotracheitis in cattle worldwide. Currently, there is no antiviral prophylactic treatment available capable of mitigating the disease impact and ...
Jian Xu +20 more
doaj +1 more source

